Media Releases - 2010

	Orchid receives US FDA approval for Levetiracetam Tablets ANDA
	Orchid registers turnover of Rs 331 crore during Q1 FY11 Net profit grows by 172% to Rs 22 crore
	Orchid to acquire US-based marketing company Karalex Pharma, LLC.
	Orchid’s consolidated turnover for FY10 increases to Rs 1343 crore
	Orchid enters into an out-licensing and distribution alliance with Alvogen to market oral non-antibiotic formulations in the US
	Orchid settles Litigation with Forest Laboratories for Memantine Tablets
	Orchid completes Business Transfer transaction with Hospira, Inc.
	Orchid registers turnover of Rs 332 crore during Q3 FY10
	Orchid receives Tentative US FDA nod for Memantine Tablets